Literature DB >> 19363858

Disfiguring scarring following mesotherapy-associated Mycobacterium cosmeticum infection.

Kenneth Beer1, Jill Waibel.   

Abstract

Mesotherapy is a popular procedure that poses risks that include scarring, contour changes and bacterial infections. The benefits of the procedure remain to be objectively delineated in a placebo-controlled, blinded study. Despite the lack of evidence to support its use, it is marketed as a "nonsurgical and safe" way to remove fat. The authors report a case of mycobacterial infection resulting from mesotherapy. This infection should be considered when a patient presents with a mesotherapy complication and should be discussed with the patient prior to the procedure. Options for treatment of the scarring are considered.

Entities:  

Mesh:

Year:  2009        PMID: 19363858

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  5 in total

1.  A neonate born with Mycobacterium cosmeticum bacteraemia.

Authors:  Wei Li Adeline Koay; Lemuel Aigbivbalu; Janak Patel
Journal:  BMJ Case Rep       Date:  2015-12-23

2.  Pneumonia due to Mycobacterium cosmeticum in a renal transplant recipient.

Authors:  Ahmed Aljishi; Marwan Jabr Alwazzeh; Mar Kristjansson
Journal:  BMJ Case Rep       Date:  2021-03-02

3.  Mycobacterium chelonae abscesses associated with biomesotherapy, Australia, 2008.

Authors:  Mihaela Ivan; Craig Dancer; Ann P Koehler; Michaela Hobby; Chris Lease
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883

4.  Draft Genome Sequence of Mycobacterium cosmeticum DSM 44829.

Authors:  Olivier Croce; Catherine Robert; Didier Raoult; Michel Drancourt
Journal:  Genome Announc       Date:  2014-04-10

5.  Molecular Identification of Nontuberculous Mycobacteria in Humans in Zimbabwe Using 16S Ribosequencing.

Authors:  Nyasha Chin'ombe; Boniface Muzividzi; Ellen Munemo; Pasipanodya Nziramasanga
Journal:  Open Microbiol J       Date:  2016-05-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.